Business
Buscar Company Acquires 70% Stake in Armorgenix, Bolstering Portfolio with Pharmaceutical Innovation and Positioning for Growth in the U.S. Antiviral and Detoxification Markets
Buscar Company Acquires 70% Stake in Armorgenix, Bolstering Portfolio with Pharmaceutical Innovation and Positioning for Growth in the U.S. Antiviral and Detoxification Markets.
About this update from Buscar Company
[{"type":"text","content":"\r\n\r\n \r\n \r\n Buscar Company Acquires 70% Stake in Armorgenix, Bolstering Portfolio with Pharmaceutical Innovation and Positioning for Growth in the U.S. Antiviral and Detoxification Markets\r\n \r\n \r\n\r\n\r\nBuscar Company Acquires 70% Stake in Armorgenix, Bolstering Portfolio with Pharmaceutical Innovation and Positioning for Growth in the U.S. Antiviral and Detoxification Markets\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\nBEVERLY HILLS, Calif., June 3, 2025 /PRNewswire/ -- Buscar Company (OTC: CGLD), a publicly traded diversified holding company headquartered in Beverly Hills, California, is thrilled to announce the acquisition of a 70% stake in Armorgenix Company through a strategic stock swap. This transformative acquisition marks a significant expansion of Buscar's portfolio into the pharmaceutical sector, complementing its established operations in natural resources and sustainable technologies. Armorgenix's expertise in advanced detoxification and antiviral solutions, including its clinically evaluated DetoxShield product, aligns seamlessly with Buscar's mission to drive innovation across high-potential industries, delivering long-term shareholder value while addressing pressing global challenges such as viral infections and environmental sustainability.\r\n\r\n \r\n \r\n \r\n \r\n \r\n \r\n\r\n \r\nTransaction Details\r\nUnder the terms of the agreement, Buscar acquires 70% of Armorgenix's equity through a stock swap, valued based on a mutually agreed-upon exchange ratio of Buscar shares. This acquisition follows Buscar's strategic 50% stake acquisition in Terramer Inc. in April 2025, further diversifying its portfolio into innovative, high-growth sectors. Armorgenix, based in Mequon, Wisconsin, will operate as a key subsidiary under Buscar's umbrella, with plans to establish a Texas-based manufacturing facility and a Wyoming-based corporation to manage intellectual property, research, and a new brand tailored for North American markets. These initiatives are expected to be operational within 24-36 months, supported by Armorgenix-led fundraising efforts to localize production and enhance market penetration.\r\nStrategic Vision and Synergies\r\nThe acquisition of Armorgenix strengthens Buscar's diversified portfolio, bridging its expertise in natural resources through Eon Discovery Inc. and sustainable materials via Terramer...